Healthcare -
Biotechnology - NASDAQ - US
$ 0.326
-1.66 %
$ 3.67 M
Market Cap
-0.01
P/E
CYCC - RESEARCH & DEVELOPMENT
Research & Development CYCC - Cyclacel Pharmaceuticals, Inc.
19.2 M
LAST VALUE
11.25%
2 YEAR CAGR
34.65%
5 YEAR CAGR
5.44%
10 YEAR CAGR